Brief: Sirnaomics Says Got IND Clearance From Taiwan Ministry Of Health & Welfare For Phase I Clinical Study Of Rnai Therapeutic Stp705
26/07/2022 02:12
July 26 (Reuters) - Sirnaomics Ltd 2257.HK :
* GETS IND CLEARANCE FROM TAIWAN MINISTRY OF HEALTH &
WELFARE FOR
PHASE I CLINICAL STUDY OF RNAI THERAPEUTIC STP705
Further company coverage: 2257.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sirnaomics
See all newsBrief: Sirnaomics To Issue 2.4 Million New Shares At Hk$4.69 Each Under General Mandate
Brief: Sirnaomics Says Chairman Purchases 38,000 Shares At Average Price Hk$5.93 Per Share
Brief: Sirnaomics Ltd To Issue 17.4 Million Subscription Shares
Brief: Sirnaomics Says Poon Hung Fai Appointed As Chairman
Brief: Sirnaomics Posts FY Net Income USD -50.2 Million